Altimmune Inc (ALT)
8.40
+0.35
(+4.35%)
USD |
NASDAQ |
Nov 21, 16:00
8.51
+0.11
(+1.31%)
After-Hours: 20:00
Altimmune Max Drawdown (5Y): 99.85% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.85% |
| September 30, 2024 | 99.85% |
| August 31, 2024 | 99.85% |
| July 31, 2024 | 99.85% |
| June 30, 2024 | 99.85% |
| May 31, 2024 | 99.85% |
| April 30, 2024 | 99.85% |
| March 31, 2024 | 99.85% |
| February 29, 2024 | 99.85% |
| January 31, 2024 | 99.85% |
| December 31, 2023 | 99.85% |
| November 30, 2023 | 99.85% |
| October 31, 2023 | 99.85% |
| September 30, 2023 | 99.85% |
| August 31, 2023 | 99.85% |
| July 31, 2023 | 99.85% |
| June 30, 2023 | 99.85% |
| May 31, 2023 | 99.85% |
| April 30, 2023 | 99.85% |
| March 31, 2023 | 99.85% |
| February 28, 2023 | 99.85% |
| January 31, 2023 | 99.85% |
| December 31, 2022 | 99.85% |
| November 30, 2022 | 99.85% |
| October 31, 2022 | 99.85% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.85% |
| August 31, 2022 | 99.85% |
| July 31, 2022 | 99.85% |
| June 30, 2022 | 99.85% |
| May 31, 2022 | 99.85% |
| April 30, 2022 | 99.85% |
| March 31, 2022 | 99.85% |
| February 28, 2022 | 99.85% |
| January 31, 2022 | 99.85% |
| December 31, 2021 | 99.85% |
| November 30, 2021 | 99.85% |
| October 31, 2021 | 99.85% |
| September 30, 2021 | 99.85% |
| August 31, 2021 | 99.85% |
| July 31, 2021 | 99.85% |
| June 30, 2021 | 99.85% |
| May 31, 2021 | 99.85% |
| April 30, 2021 | 99.85% |
| March 31, 2021 | 99.85% |
| February 28, 2021 | 99.85% |
| January 31, 2021 | 99.85% |
| December 31, 2020 | 99.85% |
| November 30, 2020 | 99.85% |
| October 31, 2020 | 99.85% |
| September 30, 2020 | 99.85% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.85%
Minimum
Nov 2019
99.85%
Maximum
Nov 2019
99.85%
Average
99.85%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| Viking Therapeutics Inc | 89.26% |
| Amgen Inc | 24.86% |
| Avid Bioservices Inc | 86.42% |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 25.17 |
| Beta (5Y) | 0.0893 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 182.4% |
| Historical Sharpe Ratio (5Y) | 0.1443 |
| Historical Sortino (5Y) | 0.5641 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.13% |